BIOA

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

• BioAge reported positive Phase 1 data for BGE-102 showing strong hsCRP reduction potentialApr 21, 2026
• BioAge announced additional positive Phase 1 data for BGE-102 NLRP3 inhibitorJan 13, 2026
• BioAge announces positive interim Phase 1 data for BGE-102, novel brain-penetrant NLRP3 inhibitorDec 5, 2025